JAYKAYBSEJaykay Enterprises LtdMediumPositive
Announced Wed, 10 Sept · 12:16 IST

Announcement under Regulation 30 of SEBI Listing Regulations - Execution of Transfer of Technology Agreement between JK Digital, WOS of Jaykay Enterprises Limited and Central Scientific ....

Strategic Transactions View source PDF

JAYKAY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

JK Digital & Advance Systems Pvt Ltd, a wholly owned subsidiary of Jaykay Enterprises, has signed a Transfer of Technology (ToT) Agreement with Central Scientific Instruments Organisation (CSIR-CSIO), Chandigarh, on September 9, 2025. The deal covers seven advanced orthopedic implant technologies used in spinal and hip surgeries, including TLIF, PLIF, buttress & shim augments, shell & wedge augments, lattice cones, cage constructs, and lattice acetabular cups, to be manufactured domestically using 3D printing and additive manufacturing. The technology licence is valid for 7 years and supports the government's 'Make in India' push in medical devices by reducing import reliance. The company claims this positions it as one of the first Indian players to offer indigenously manufactured 3D-printed lattice implants at affordable prices. No equity, related-party, or board-level changes are involved in the transaction.

Likely market impact

Positive long-term strategic move as Jaykay Enterprises expands into high-value indigenous medical device manufacturing, but near-term revenue impact remains uncertain since this is a technology licensing deal without disclosed financial terms. Shareholders should watch for future updates on commercial production timelines and revenue contribution from this segment.